As of Jun 24
| -0.05 / -2.33%|
The 5 analysts offering 12-month price forecasts for Galena Biopharma Inc have a median target of 4.00, with a high estimate of 5.00 and a low estimate of 2.00. The median estimate represents a +90.48% increase from the last price of 2.10.
The current consensus among 5 polled investment analysts is to Buy stock in Galena Biopharma Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.